Dornase Alfa
1 NDC across 1 manufacturer|0 Generic,1 Brand
Dornase Alfa is used to treat bronchitis and cystic fibrosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $2 million on Dornase Alfa across 443 claims for 100 beneficiaries.
Dornase Alfa is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $53.08 to $53.08 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$53.08 – $53.08
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DORNASE ALFA
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PULMOZYME 1 MG/ML AMPUL | $53.0762 per ML | +0.04% |
Frequently Asked Questions
What is Dornase Alfa used to treat?
Dornase Alfa is used to treat bronchitis and cystic fibrosis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Dornase Alfa?
In 2024, Medicare Part D spent $2 million on Dornase Alfa across 443 claims for 100 beneficiaries.
How many Dornase Alfa products are on the market?
The Dornase Alfa drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Dornase Alfa?
NADAC reference prices for Dornase Alfa range from $53.0762 to $53.0762 per ML.
Which manufacturers make Dornase Alfa?
1 manufacturer lists Dornase Alfa in NADAC. Ranked by number of NDCs, the largest are Genentech, Inc. (1).
How has the price of Dornase Alfa changed recently?
Over the past 7 days, 1 Dornase Alfa NDC rose and 0 fell, with a market-wide average change of +0.0%.